Automation of Glycan and Peptide Mapping: Leveraging Software to Improve Efficiency and Quality
Who's speaking at this Webinar?
Thomas Wesley Powers
Principal Scientist Pfizer
Customer Success Scientist Protein Metrics Inc.
Glycan and peptide mapping should be easy to accomplish as part of routine characterization. However, it is often a tedious interpretation process where results can be fraught with risk of errors in transcription and labeling, especially when including MS2 or UV data in addition to MS1.
In this webinar, Thomas Powers, Principal Scientist at Pfizer, will demonstrate how his company eliminated the risks associated with manual interrogation of mapping data by creating automated workflows that have improved the efficiency, quality, and consistency of their results.
Attend this webinar to learn:
How to identify and reduce the data analysis risks associated with peptide mapping
How to create automated workflows that accommodate a company’s specific nomenclature for released N-glycans and peptides
How to improve efficiency, quality and consistency in routine characterization and thereby enhance scientific report writing and regulatory filing submissions
Like what you just read? You can find similar content on the communities below.Biopharma Cancer Research Cell Science Drug Discovery Informatics Proteomics & Metabolomics Neuroscience
To personalize the content you see on Technology Networks homepage, Log In or Subscribe for FreeLOGIN SUBSCRIBE FOR FREE